Publicaciones (260) Publicaciones de MARÍA JOSÉ PARELLADA REDONDO

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389

  2. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

    Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338

  3. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

    Psychological Medicine, Vol. 54, Núm. 7, pp. 1339-1349

  4. Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk

    Psychiatry Research, Vol. 332

  5. Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.

    Psychiatry Research, Vol. 334

  6. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

  7. Prevalence and Correlates of the Concurrence of Autism Spectrum Disorder and Obsessive Compulsive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis

    Brain Sciences, Vol. 14, Núm. 4

  8. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

    Schizophrenia Research, Vol. 267, pp. 534-545

  9. Psychopharmacology in children and adolescents: unmet needs and opportunities

    The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation

    Frontiers in Genetics, Vol. 14

  3. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

  4. Autism care pathway in Europe

    European Psychiatry, Vol. 66, Núm. 1

  5. Autism with co-occurring epilepsy care pathway in Europe

    European Psychiatry, Vol. 66, Núm. 1

  6. Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies

    Autism Research, Vol. 16, Núm. 10, pp. 2021-2034

  7. Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160

  8. Country-level gender inequality is associated with structural differences in the brains of women and men

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 20

  9. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  10. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    Psychiatry Research, Vol. 323

  11. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

    Revista de Psiquiatria y Salud Mental